Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: The EPOCAP study

Therapeutic Advances in Respiratory Disease

Volumn 4, Issue 4, 2010, Pages 215-223

  Murio, Cristina ^a   Soler, Xavier ^b   Pérez, Maite ^c   Calero, Gabriel ^d   Ruiz Manzano, Juan ^d  

^a HOSPITAL GENERAL DE CATALUNYA   (Spain)

^b Division of Pulmonary and Critical Care Medicine   (United States)

^c Laboratorios Almirall SA ^*  (Spain)

^d CENTRO MÉDICO TEKNON   (Spain)

Author keywords

acute exacerbation; chronic obstructive pulmonary disease (COPD); primary care; pulmonary function test; spirometry; treatment

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MACROLIDE; MUCOLYTIC AGENT; QUINOLONE; SHORT ACTING DRUG; THEOPHYLLINE;

AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN THERAPY; PHYSIOTHERAPY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING; SPAIN; SPIROMETRY; SPUTUM;

ACUTE DISEASE; AGED; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPAIN; SPIROMETRY; SPUTUM;

EID: 77955574583     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465810374611     Document Type: Article

References (28)

1. Anthonisen, N.R., Manfreda, J., Warren, C.P., Hershfield, E.S., Harding, G.K. and Nelson, N.A. ( 1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106: 196-204.
2. Barbera, J.A., Peces-Barba, G., Agusti, A.G., Izquierdo, J.L., Monso, E., Montemayor, T. et al. (2001) [Clinical Guidelines for the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease]. Arch Bronconeumol 37: 297-316.
3. Bellone, A., Lascioli, R., Raschi, S., Guzzi, L. and Adone, R. ( 2000) Chest physical therapy in patients with acute exacerbation of chronic bronchitis: effectiveness of three methods. Arch Phys Med Rehabil 81: 558-560.
4. Braman, S.S. ( 2006) Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 129: 95S-103S.
5. Brunton, S., Carmichael, B.P., Colgan, R., Feeney, A.S., Fendrick, A.M., Quintiliani, R. et al. (2004) Acute exacerbation of chronic bronchitis: a primary care consensus guideline. Am J Manag Care 10: 689-696.
6. Burge, P.S., Calverley, P.M., Jones, P.W., Spencer, S., Anderson, J.A. and Maslen, T.K. ( 2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 320: 1297-1303.
7. Burge, S. and Wedzicha, J.A. ( 2003) COPD exacerbations: definitions and classifications. Eur Respir J Suppl 41: 46s-53s.
8. Fagerstrom, K.O. ( 2005) Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration 72: 216-220.
9. MacNee, W. ( 2003) Acute exacerbations of COPD. Swiss Med Wkly 133: 247-257.
10. Macnee, W. and Calverley, P.M. ( 2003) Chronic obstructive pulmonary disease. 7: management of COPD. Thorax 58: 261-265.
11. Mannino, D.M. ( 2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121: 121S-126S.
12. Miravitlles, M., Anzueto, A., Ewig, S., Legnani, D. and Stauch, K. (2009) Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Ther Adv Respir Dis 3: 267-277.
13. Miravitlles, M., De La Roza, C., Naberan, K., Lamban, M., Gobartt, E. and Martin, A. ( 2007) Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 101: 1753-1760.
14. Miravitlles, M., Guerrero, T., Mayordomo, C., Sanchez-Agudo, L., Nicolau, F. and Segu, J.L. ( 2000) Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 67: 495-501.
15. Miravitlles, M., Mayordomo, C., Artes, M., Sanchez-Agudo, L., Nicolau, F. and Segu, J.L. ( 1999a) Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional De La Limitacion Obstructiva Al Flujo Aereo. Respir Med 93: 173-179.
16. Miravitlles, M., Murio, C. and Guerrero, T. ( 2001) Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. Dafne Study Group. Eur Respir J 17: 928-933.
17. Miravitlles, M., Murio, C., Guerrero, T. and Gisbert, R. ( 2002) Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 121: 1449-1455.
18. Miravitlles, M., Murio, C., Guerrero, T. and Segu, J.L. ( 1999b) [Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care]. Arch Bronconeumol 35: 173-178.
19. Naberan, K., De La Roza, C., Lamban, M., Gobartt, E., Martin, A. and Miravitlles, M. ( 2006) [Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol 42: 638-644.
20. Paggiaro, P.L., Dahle, R., Bakran, I., Frith, L., Hollingworth, K. and Efthimiou, J. ( 1998) Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet 351: 773-780.
21. Poole, P.J. and Black, P.N. ( 2001) Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. BMJ 322: 1271-1274.
22. Puhan, M.A., Vollenweider, D., Latshang, T., Steurer, J. and Steurer-Stey, C. ( 2007) Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res 8: 30.
23. Rabe, K.F., Hurd, S., Anzueto, A., Barnes, P.J., Buist, S.A., Calverley, P. et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
24. Snow, V., Lascher, S. and Mottur-Pilson, C. ( 2001a) Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 134: 595-599.
25. Snow, V., Lascher, S. and Mottur-Pilson, C. ( 2001b) The evidence base for management of acute exacerbations of COPD: clinical practice guideline, part 1. Chest 119: 1185-1189.
26. Taccola, M., Bancalari, L., Ghignoni, G. and Paggiaro, P.L. ( 1999) Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease. Monaldi Arch Chest Dis 54: 302-306.
27. Van Schayck, C.P. and Kaper, J. ( 2006) Smoking and COPD: will they ever vanish into smoke? Prim Care Respir J 15: 81-83.
28. Viejo-Banuelos, J.L., Pueyo-Bastida, A. and Fueyo-Rodriguez, A. ( 2006) Characteristics of outpatients with COPD in daily practice: the E4 Spanish project. Respir Med 100: 2137-2143.